Copyright © 2000 by the European Society of Cardiology.
Sudden death in patients and relatives with the syndrome of right bundle branch block, ST segment elevation in the precordial leads V1to V3and sudden death
a Cardiovascular Research and Teaching Institute, Aalst, Belgium
b Baylor College of Medicine, Houston, Texas, U.S.A.
c Unitat d'Arritmias, Hospital Clinic, Barcelona, Spain
revised June 7, 1999; accepted June 9, 1999
Abstract
Background The syndrome with an electrocardiographic pattern of right bundle branch block, ST segment elevation in leads V1to V3and sudden death is genetically determined and caused by mutations in the cardiac sodium channel. The inheritance of the disease is autosomal dominant. Sudden death may, however, occur from a variety of causes in relatives and patients with this syndrome.
Patients and Methods Twenty-five Flemish families with this syndrome with a total of 334 members were studied. Affected members were recognized by means of a typical electrocardiogram either occurring spontaneously or after the intravenous administration of antiarrhythmic drugs. Sudden deaths in these families were classified as related or not to the syndrome by analysis of the data at the time of the event, mode of inheritance of the disease, and data provided by survivors.
Results Of the 25 families with the syndrome, 18 were symptomatic (at least one sudden death related to the syndrome) and seven were asymptomatic (no sudden deaths related to the syndrome). In total, there were 42 sudden cardiac deaths (12% incidence). Twenty-four sudden deaths were related to the syndrome and all occurred in symptomatic families. Eighteen sudden deaths (43% of total sudden deaths) were not related to the syndrome (nine cases) or were of unclear cause (nine cases). Three of them occurred in two asymptomatic families and the remaining 15 in five symptomatic families. Twenty-four of the 50 affected members (47%) suffered (aborted) sudden death and 18 of the 284 unaffected members (6%). This difference in the incidence of sudden death was statistically significant (P<0·0001). Patients with (aborted) sudden death caused by the syndrome were younger than patients with sudden death of other or unclear causes (38±4 years vs 59±3 years respectively,P =0·0003).
Conclusions In families at high risk of sudden death because of genetically determined diseases, the main cause of sudden death remains the disease. However, almost the half of sudden deaths are caused by unrelated diseases or are of unclear cause. Accurate classification of the causes of sudden death is mandatory for appropriate analysis of the causes of death when designing preventive treatments.
Key Words: Sudden death, right bundle branch block ST elevation syndrome, ventricular fibrillation, Brugada syndrome, genetics of arrhythmias
f1 Correspondence: Pedro Brugada, MD. Professor of Cardiology, Cardiovascular Research and Teaching Institute Aalst, Cardiovascular Center, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium.
References
- Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 1992;20:1391–1396[Abstract]
- Nademanee K, Veerakul G, Nimmannit S. Arrhythmogenic markers for the sudden unexplained death syndrome in Thai men. Circulation. 1997;96:2595–2600
[Abstract/Free Full Text] - Tasanavivat P, Chiravatkul AZ, Klungboonkrong V. Sudden and unexplained deaths in sleep (Laitai) of young men in rural northeastern Thailand. In J Epidemiol. 1992;21:904–910
- Brugada J, Brugada P. Further characterization of the syndrome of right bundle branch block, persistent ST segment elevation and sudden death. J Cardiovasc Electrophysiology. 1997;:325–331
- Brugada J, Brugada R, Brugada P. Right bundle branch block and ST segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 1998;97:457–460
[Abstract/Free Full Text] - Atarashi H, Ogawa S, Harumi K. Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads. Am J Cardiol. 1996;78:581–583[CrossRef][Web of Science][Medline]
- Kanasuki H, Ahnishi S, Ohtuka M. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation. 1995;95:2277–2285
- D' Onofrio A, Cuomo S, Musto B, Boccalatte A. Right bundle branch block, persistent ST-segment elevation in V1–V3 and sudden cardiac death: always a distinct syndrome? G Ital Cardiol. 1995;25:1171–1175[Medline]
- Matsuo K, Shimizu W, Kurita T, Inagaki M, Aihara N, Kamakura S. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol. 1998;9:508–512[Web of Science][Medline]
- Kobayashi T, Shintani U, Yamamoto T. Familial occurrence of electrocardiographic abnormalities of the Brugada-type. Intern Med. 1996;35:637–640[Web of Science][Medline]
- Viskin S, Belhassen B. Clinical problem-solving: when you live only twice. N Engl J Med. 1995;332:1221–1225
[Free Full Text] - Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiology. 1993;4:356–358
- Alings M, Wilde A. ‘Brugada’ syndrome. Clinical data and suggested pathophysiological mechanisms. Circulation. 1999;99:666–673
[Free Full Text] - Chen Q, Kirsch GE, Zhang D. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293–296[CrossRef][Medline]
- Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vinvent GM. Multiple mechanisms in the long QT syndrome: current knowledge, gaps and future directions. Circulation. 1996;94:1996–2012
[Abstract/Free Full Text] - Priori S, Barhanin J, Hauer RNW. Genetic and molecular basis of cardiac arrhythmias. Eur Heart J. 1999;20:174–195
[Free Full Text] - Myazaki T, Mitamura H, Miyoshi S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996;27:1061–1070[Abstract]
- Brugada J, Brugada R, Wang Q, Potenza D, Brugada P, Towbin J. Unmasking of genotype and phenotype abnormalities by administration of class I antiarrhythmic drugs in patients with sudden death (Abstr). Eur Heart J. 1998;19:557
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. D. Krahn, J. S. Healey, V. Chauhan, D. H. Birnie, C. S. Simpson, J. Champagne, M. Gardner, S. Sanatani, D. V. Exner, G. J. Klein, et al. Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) Circulation, July 28, 2009; 120(4): 278 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Krahn, M. Gollob, R. Yee, L. J. Gula, A. C. Skanes, B. D. Walker, and G. J. Klein Diagnosis of Unexplained Cardiac Arrest: Role of Adrenaline and Procainamide Infusion Circulation, October 11, 2005; 112(15): 2228 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Sangwatanaroj, S Prechawat, B Sunsaneewitayakul, S Sitthisook, P Tosukhowong, and K Tungsanga New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives Eur. Heart J., December 2, 2001; 22(24): 2290 - 2296. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Gussak, P. Bjerregaard, and S. C. Hammill Clinical diagnosis and risk stratification in patients with brugada syndrome J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1635 - 1638. [Full Text] [PDF]
|
|
|
|
|
|
A.A.M. Wilde and S.G. Priori Brugada syndrome and sudden death Eur. Heart J., September 1, 2000; 21(17): 1483 - 1483. [PDF]
|
|
|
|
|
|
J. Farre The Brugada syndrome: do we need more than the 12-lead ECG? Eur. Heart J., February 2, 2000; 21(4): 264 - 265. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||